Healthy Volunteers Needed: BI 3000202 Interaction Study

We are testing how the new medication BI 3000202 affects the absorption of rosuvastatin and digoxin in healthy people. This research aims to improve our understanding of these drug interactions.

Safety phase (I)Internal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Boehringer Ingelheim Pharma GmbH & Co. KG

Global Clinical Development & Operations

Biberach an der Riß, Germany

Sponsor: Boehringer Ingelheim International GmbH

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.